Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raffaella Greco

Showing results (131-140 of 190) with videos related to

Pageof 19
Sort By:
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Bone Marrow Transplantation|February 6, 2022
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experienceSimona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Current Research in Translational Medicine|June 18, 2023
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experienceEdoardo Campodonico, Elisabetta Xue, Simona Piemontese, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Expert Opinion on Biological Therapy|May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 10, 2021
Of mitochondrion and COVID-19Khalid Omer Alfarouk, Sari T S Alhoufie, Abdelhameed Hifny, et al.
Bone Marrow Transplantation|May 19, 2022
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022John A Snowden, Isabel Sánchez-Ortega, Selim Corbacioglu, et al.
Blood Advances|January 25, 2022
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantationFrancesca Lorentino, Elisabetta Xue, Sara Mastaglio, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Pageof 19

Showing results (131-140 of 190) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|April 19, 2018
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWPRaffaella Greco, Fabio Ciceri, Maddalena Noviello, et al.
Bone Marrow Transplantation|February 6, 2022
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experienceSimona Piemontese, Lorenzo Lazzari, Annalisa Ruggeri, et al.
Therapeutic Advances in Hematology|June 24, 2022
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donorsCarmine Liberatore, Maria Teresa Lupo Stanghellini, Francesca Lorentino, et al.
Current Research in Translational Medicine|June 18, 2023
Splenic irradiation prior to allogeneic transplant conditioning in myelofibrosis: A pilot experienceEdoardo Campodonico, Elisabetta Xue, Simona Piemontese, et al.
Transplantation and Cellular Therapy|June 4, 2021
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell TransplantRaffaella Greco, Francesca Lorentino, Serena Albanese, et al.
Expert Opinion on Biological Therapy|May 17, 2017
New drugs and allogeneic hematopoietic stem cell transplantation for hematological malignancies: do they have a role in bridging, consolidating or conditioning transplantation treatment?Francesca Patriarca, Luisa Giaccone, Francesco Onida, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry|June 10, 2021
Of mitochondrion and COVID-19Khalid Omer Alfarouk, Sari T S Alhoufie, Abdelhameed Hifny, et al.
Bone Marrow Transplantation|May 19, 2022
Indications for haematopoietic cell transplantation for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2022John A Snowden, Isabel Sánchez-Ortega, Selim Corbacioglu, et al.
Blood Advances|January 25, 2022
Letermovir reduces chronic GVHD risk in calcineurin inhibitor-free GVHD prophylaxis after hematopoietic cell transplantationFrancesca Lorentino, Elisabetta Xue, Sara Mastaglio, et al.
Bone Marrow Transplantation|July 19, 2023
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovirGiorgio Orofino, Elisabetta Xue, Matteo Doglio, et al.
Pageof 19